Waiver of Informed Consent in Research
A waiver of informed consent permits research to proceed without obtaining prospective written or verbal consent from participants. This exception to the standard informed consent requirement applies to specific low-risk research scenarios where obtaining consent is impractical, unnecessary, or would compromise research validity. In the U.S., the regulations (45 CFR 46.116) specify four criteria that must be met for an IRB to approve a waiver; similar criteria apply in the UK (Research Ethics Committee) and EU jurisdictions. Waivers are not automatic; researchers must request them explicitly and justify them to the ethics committee, which determines whether the criteria are met.
出典記録
引用は手法の出典記録からそのままコピーされています。それらからレベルごとの検証は推論されません。
- U.S. Department of Health and Human Services. (2018). Protection of Human Subjects. Code of Federal Regulations Title 45, Part 46, Section 46.116(c). · URL
- U.S. Department of Health and Human Services, Office for Human Research Protections. (2019). Waiver or Alteration of Informed Consent. National Institutes of Health. · URL
- U.S. Food and Drug Administration. (2015). Guidance for Industry: Waiver or Alteration of Informed Consent for in vitro Diagnostic Device Studies Using Leftover Human Specimens. · URL
- Health Research Authority. (2021). Guidance for Applicants: Research Without Consent. UK Research Ethics Service. · URL
キュレーションされた主張
主張は証拠台帳に永続化され、それぞれが独自の評価を持っています。
このビューは、台帳に主張評価がない場合、主張評価を生成しません。
関連手法
手法グラフから生成され、機械が提案した関係として表示されます — 証拠主張は推論されません。